17-35411724-T-C

Position:

• chr17-35411724-T-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2 BP4_Moderate

The NM_018042.5(SLFN12):​c.1351A>G​(p.Ser451Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

• Frequency: Genomes: not found (cov: 32)
• Consequence: SLFN12 NM_018042.5 missense
• Clinical Significance: Uncertain significance criteria provided, single submitter U:1
• Conservation: PhyloP100: -0.218

Genes affected

SLFN12 (HGNC:25500): (schlafen family member 12) Predicted to act upstream of or within negative regulation of cell population proliferation. [provided by Alliance of Genome Resources, Apr 2022]

ACMG classification

Verdict is Uncertain_significance. Variant got 0 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• BP4: Computational evidence support a benign effect (MetaRNN=0.07990241).

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
SLFN12	NM_018042.5	c.1351A>G	p.Ser451Gly	missense_variant	4/4	ENST00000304905.10
SLFN12	NM_001289009.2	c.1351A>G	p.Ser451Gly	missense_variant	4/4
SLFN12	XM_005257995.6	c.1351A>G	p.Ser451Gly	missense_variant	5/5
SLFN12	XM_024450822.2	c.1351A>G	p.Ser451Gly	missense_variant	6/6

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
SLFN12	ENST00000304905.10	c.1351A>G	p.Ser451Gly	missense_variant	4/4	1	NM_018042.5	P1

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome Cov.: 31

GnomAD4 genome Cov.: 32

ClinVar

Significance: Uncertain significance

Submissions summary: Uncertain:1

Revision: criteria provided, single submitter

Submissions by phenotype

not specified Uncertain:1

Uncertain significance, criteria provided, single submitter

clinical testing

Ambry Genetics

Oct 03, 2022

The c.1351A>G (p.S451G) alteration is located in exon 4 (coding exon 3) of the SLFN12 gene. This alteration results from a A to G substitution at nucleotide position 1351, causing the serine (S) at amino acid position 451 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Benign	0.12
BayesDel_addAF	Benign	-0.32	T
BayesDel_noAF	Benign	-0.69
CADD	Benign	2.3
DANN	Benign	0.96
DEOGEN2	Benign	0.080	T;T;T
Eigen	Benign	-0.92
Eigen_PC	Benign	-1.0
FATHMM_MKL	Benign	0.023	N
LIST_S2	Benign	0.29	.;.;T
M_CAP	Benign	0.011	T
MetaRNN	Benign	0.080	T;T;T
MetaSVM	Benign	-0.97	T
MutationAssessor	Benign	1.6	L;L;L
MutationTaster	Benign	1.0	N;N;N
PrimateAI	Benign	0.24	T
PROVEAN	Benign	-2.3	N;N;N
REVEL	Benign	0.018
Sift	Uncertain	0.026	D;D;D
Sift4G	Benign	0.087	T;T;T
Polyphen		0.041	B;B;B
Vest4		0.078
MutPred		0.34		Loss of stability (P = 0.1315);Loss of stability (P = 0.1315);Loss of stability (P = 0.1315);
MVP		0.10
MPC		0.048
ClinPred		0.054	T
GERP RS		0.87
Varity_R		0.047
gMVP		0.13

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.010		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr17-33738743;